AUTHOR=Letose Fikru , Tusa Alemtsehay , Sahlu Degemu , Miherite Yohannis 

TITLE=Discontinuation of long-acting reversible contraceptive methods and associated factors among reproductive-age women in Shashemene town, Oromia, Ethiopia

JOURNAL=Frontiers in Global Women's Health

VOLUME=Volume 5 - 2024

YEAR=2024

URL=https://www.frontiersin.org/journals/global-womens-health/articles/10.3389/fgwh.2024.1269302

DOI=10.3389/fgwh.2024.1269302

ISSN=2673-5059

ABSTRACT=The early termination of long-acting reversible contraceptives raises issues for the healthcare system and has the potential to affect public health. Long-acting reversible contraception is now more widely available and used, although a sizable percentage of women still stop using it. Therefore, this study aims to assess factors associated with the discontinuation of the long-acting reversible contraceptive method among female users of health facilities in Shashemane Town.Methods: A facility-based cross-sectional study was done in Shashemane town among 410 study participants in 9 facilities. The study participants were selected by using a systematic sampling method. Data were collected by using structured interviewer-administered questionnaires and entered into epi-data version 4.6.0.2 and exported to SPSS version 25 for analysis. Bivariate and multivariable logistic regressions were used to examine the association between independent variables and discontinuation of the long-acting reversible contraceptives. The results were presented using the Odds Ratio at 95% CI. P < 0.05 ware used to dictate statistical significance.The overall prevalence of women who removed the long-acting reversible contraceptive method before the due date was 57.2%. Factors such as having an occupation as a housewife, desire to become pregnant, unwarned side effects, effectiveness, and dissatisfaction with the service provided were positively associated with discontinuation of the contraception.The prevalence of the discontinuation of reversible long-acting contraceptives was high. Pre-insertion effective counseling about the benefits, follow-up care and management for side effects, and client reassurance are recommended.